SCHEMBL17099181

SCHEMBL17099181

CCOC(=O)[C@H]1CC[C@H](n2ncc(C(=O)N(CC(=O)c3c(N)cccc3Cl)Cc3cc(F)cc(F)c3)c2C(F)(F)F)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.35
POLB P06746 2/20 0.34
TP53 P04637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NR3C1 P04150 6/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
MAPT P10636 2/20 0.33
MAPK1 P28482 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CCR2 P41597 2/20 0.32
KCNH2 Q12809 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17099183 1.00 HSD11B1 (0.35) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097638 0.93 POLB (0.34) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097642 0.93 POLB (0.34) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097522 0.91 POLB (0.35) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097524 0.91 POLB (0.35) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097956 0.91 HSD11B1 (0.34) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097954 0.91 HSD11B1 (0.34) HSD11B1POLBTP53TDP1NR3C1
SCHEMBL17097422 0.90 NR3C1 (0.33) NR3C1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL17097419 0.90 NR3C1 (0.33) NR3C1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL17097778 0.90 ALDH1A1 (0.37) HSD11B1POLBTP53TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA HSD11B1 195/4885POLB 4102/4885TP53 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.